Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 6
Submit an article Journal homepage
208
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Incidence of death and recurring acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US

Judith J. StephensonHealthCore, Inc., Wilmington, DE, USACorrespondence[email protected]
,
Chun-Lan ChangHealthCore, Inc. (at the time of the study), Wilmington, DE, USA
,
Gail DeVecchis WygantAstraZeneca LP (at the time of the study), Wilmington, DE, USA
,
Ole HauchAstra Zeneca LP, Wilmington, DE, USA
&
Mark J. CzirakyHealthCore, Inc., Wilmington, DE, USA
Pages 1079-1087 | Accepted 28 Feb 2011, Published online: 28 Mar 2011

References

  • Alexander JH. The current state of antiplatelet therapy in acute coronary syndromes: the data and the real world. Cleve Clin J Med 2009;76(Suppl 1):S16-23
  • Arora RR, Rai F. Antiplatelet intervention in acute coronary syndrome. Am J Ther 2009;16:e29-40
  • Ferrieres J, Bakhai A, Iniguez A, et al. Treatment patterns in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Curr Med Res Opin 2010;26:2193-202
  • Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33
  • Steinhubl SR, Berger PB, Mann III JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20
  • Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502
  • Main C, Palmer S, Griffin S, et al. Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation. Health Technol Assess 2004;8:iii-xvi, 1
  • Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007;50:e1-157
  • Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008;299:532-9
  • Ho PM, Tsai TT, Wang TY, et al. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system. Circ Cardiovasc Qual Outcomes 2010;3:303-8
  • Collet JP, Montalescot G, Steg PG, et al. Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial. Arch Cardiovasc Dis 2009;102:485-96
  • Wiederkehr D, Ogbonnaya A, Casciano R, et al. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population. Curr Med Res Opin 2009;25:2327-34
  • Wiederkehr D, Berenson K, Casciano R, et al. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network. Curr Med Res Opin 2009;25:2317-25
  • Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease. Diabetes 2006;55:780-84
  • Valgimigli M, Campo G, Arcozzi C, et al. Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa inhibitor infusion in patients with myocardial infarction: results from the STRATEGY study. J Am Coll Cardiol 2007;50:138-45
  • Sibbing D, Stegherr J, Braun S, et al. A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment. J Am Coll Cardiol 2010;55:558-65
  • Frelinger III AL, Barnard MR, Fox ML, et al. The Platelet Activity After Clopidogrel Termination (PACT) study. Circ Cardiovasc Interv 2010;3:442-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.